Collegium Pharmaceutical
(NASDAQ) COLL
Collegium Pharmaceutical Financials at a Glance
Market Cap
$1.08B
Revenue (TTM)
$796.33M
Net Income (TTM)
$74.95M
EPS (TTM)
$2.04
P/E Ratio
16.38
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$34.77
Volume
317,954.566
Open
$33.92
Price
$34.77
Volume
317,954.566
Open
$33.92
Previous Close
$34.62
Daily Range
$33.79 - $34.87
52-Week Range
$29.19 - $50.79
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$34.77
Volume
317,954.566
Open
$33.92
Previous Close
$34.62
Daily Range
$33.79 - $34.87
52-Week Range
$29.19 - $50.79
Estimated Earnings Date
Aug 6, 2026
COLL News
COLL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Collegium Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
423
CEO
Vikram Karnani, MBA
Website
www.collegiumpharma.comHeadquarters
Stoughton, MA 02072, US
COLL Financials
Key Financial Metrics (TTM)
Gross Margin
60.68%
Operating Margin
23.85%
Net Income Margin
9.41%
Return on Equity
26.74%
Return on Capital
15.06%
Return on Assets
4.54%
Earnings Yield
6.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.08B
Shares Outstanding
32.43M
Volume
317.95K
Avg. Volume
468.99K
Financials (TTM)
Gross Profit
$483.18M
Operating Income
$189.91M
EBITDA
$609.91M
Operating Cash Flow
$331.04M
Capital Expenditure
-$1.21M
Free Cash Flow
$329.83M
Cash & ST Invst.
$421.75M
Total Debt
$808.06M
Collegium Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$193.52M
+8.9%
Gross Profit
$117.25M
+20.5%
Gross Margin
60.59%
N/A
Market Cap
$1.08B
N/A
Market Cap/Employee
$3.04M
N/A
Employees
357
N/A
Net Income
$14.50M
+499.8%
EBITDA
$90.54M
+12.5%
Quarterly Fundamentals
Total Cash
$421.75M
+113.2%
Total Debt
$808.06M
-4.3%
Accounts Receivable
$228.76M
+0.0%
Inventory
$42.74M
+14.8%
Long Term Debt
$777.77M
-0.1%
Short Term Debt
$34.07M
-48.3%
Return on Assets
4.54%
N/A
Return on Invested Capital
15.61%
N/A
Free Cash Flow
$56.84M
+4.1%
Operating Cash Flow
$57.11M
+3.1%